ADESSO SE (ADN1.DE) Fundamental Analysis & Valuation
FRA:ADN1 • DE000A0Z23Q5
Current stock price
56.1 EUR
+0.6 (+1.08%)
Last:
This ADN1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ADN1.DE Profitability Analysis
1.1 Basic Checks
- ADN1 had positive earnings in the past year.
- ADN1 had a positive operating cash flow in the past year.
- ADN1 had positive earnings in each of the past 5 years.
- ADN1 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of 2.45%, ADN1 is not doing good in the industry: 61.64% of the companies in the same industry are doing better.
- Looking at the Return On Equity, with a value of 10.90%, ADN1 is in line with its industry, outperforming 47.95% of the companies in the same industry.
- ADN1's Return On Invested Capital of 5.23% is on the low side compared to the rest of the industry. ADN1 is outperformed by 64.38% of its industry peers.
- ADN1 had an Average Return On Invested Capital over the past 3 years of 3.16%. This is significantly below the industry average of 12.44%.
- The 3 year average ROIC (3.16%) for ADN1 is below the current ROIC(5.23%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROIC | 5.23% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
1.3 Margins
- ADN1 has a worse Profit Margin (0.99%) than 64.38% of its industry peers.
- In the last couple of years the Profit Margin of ADN1 has declined.
- Looking at the Operating Margin, with a value of 2.96%, ADN1 is doing worse than 68.49% of the companies in the same industry.
- ADN1's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 85.30%, ADN1 is in the better half of the industry, outperforming 76.71% of the companies in the same industry.
- ADN1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% |
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
2. ADN1.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ADN1 is creating some value.
- The number of shares outstanding for ADN1 has been reduced compared to 1 year ago.
- ADN1 has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for ADN1 has been reduced compared to a year ago.
2.2 Solvency
- ADN1 has an Altman-Z score of 3.43. This indicates that ADN1 is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.43, ADN1 belongs to the top of the industry, outperforming 80.82% of the companies in the same industry.
- The Debt to FCF ratio of ADN1 is 7.88, which is on the high side as it means it would take ADN1, 7.88 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 7.88, ADN1 is doing worse than 65.75% of the companies in the same industry.
- ADN1 has a Debt/Equity ratio of 1.60. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.60, ADN1 is not doing good in the industry: 73.97% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Altman-Z | 3.43 |
ROIC/WACC1.03
WACC5.07%
2.3 Liquidity
- ADN1 has a Current Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.30, ADN1 is in line with its industry, outperforming 58.90% of the companies in the same industry.
- ADN1 has a Quick Ratio of 1.30. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
- ADN1's Quick ratio of 1.30 is fine compared to the rest of the industry. ADN1 outperforms 64.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 |
3. ADN1.DE Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 200.98% over the past year.
- The earnings per share for ADN1 have been decreasing by -15.02% on average. This is quite bad
- Looking at the last year, ADN1 shows a quite strong growth in Revenue. The Revenue has grown by 12.60% in the last year.
- Measured over the past years, ADN1 shows a very strong growth in Revenue. The Revenue has been growing by 23.60% on average per year.
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
3.2 Future
- ADN1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.90% yearly.
- The Revenue is expected to grow by 10.64% on average over the next years. This is quite good.
EPS Next Y79.75%
EPS Next 2Y72.14%
EPS Next 3Y59.17%
EPS Next 5Y40.9%
Revenue Next Year11.29%
Revenue Next 2Y11.26%
Revenue Next 3Y11.01%
Revenue Next 5Y10.64%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. ADN1.DE Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 17.59, the valuation of ADN1 can be described as rather expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of ADN1 is on the same level as its industry peers.
- When comparing the Price/Earnings ratio of ADN1 to the average of the S&P500 Index (26.78), we can say ADN1 is valued slightly cheaper.
- Based on the Price/Forward Earnings ratio of 10.38, the valuation of ADN1 can be described as reasonable.
- Based on the Price/Forward Earnings ratio, ADN1 is valued a bit cheaper than the industry average as 73.97% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 23.54. ADN1 is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.59 | ||
| Fwd PE | 10.38 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ADN1 is valued a bit cheaper than 76.71% of the companies in the same industry.
- 76.71% of the companies in the same industry are more expensive than ADN1, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.84 | ||
| EV/EBITDA | 5.01 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- ADN1's earnings are expected to grow with 59.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y72.14%
EPS Next 3Y59.17%
5. ADN1.DE Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.39%, ADN1 has a reasonable but not impressive dividend return.
- In the last 3 months the price of ADN1 has falen by -38.62%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- ADN1's Dividend Yield is comparable with the industry average which is at 2.76.
- ADN1's Dividend Yield is slightly below the S&P500 average, which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.39% |
5.2 History
- The dividend of ADN1 is nicely growing with an annual growth rate of 15.65%!
Dividend Growth(5Y)15.65%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
- ADN1 pays out 31.75% of its income as dividend. This is a sustainable payout ratio.
- ADN1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.75%
EPS Next 2Y72.14%
EPS Next 3Y59.17%
ADN1.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ADN1 (4/10/2026, 7:00:00 PM)
56.1
+0.6 (+1.08%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-31 2026-03-31/amc
Earnings (Next)05-11 2026-05-11
Inst Owners19.64%
Inst Owner ChangeN/A
Ins Owners50.29%
Ins Owner ChangeN/A
Market Cap366.33M
Revenue(TTM)2.10B
Net Income(TTM)20.84M
Analysts83.33
Price Target128.52 (129.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.39% |
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP31.75%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.43%
PT rev (3m)1.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.59 | ||
| Fwd PE | 10.38 | ||
| P/S | 0.17 | ||
| P/FCF | 7.84 | ||
| P/OCF | 4.72 | ||
| P/B | 1.92 | ||
| P/tB | 7.23 | ||
| EV/EBITDA | 5.01 |
EPS(TTM)3.19
EY5.69%
EPS(NY)5.4
Fwd EY9.63%
FCF(TTM)7.16
FCFY12.76%
OCF(TTM)11.9
OCFY21.2%
SpS322.11
BVpS29.27
TBVpS7.75
PEG (NY)0.22
PEG (5Y)N/A
Graham Number45.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.45% | ||
| ROE | 10.9% | ||
| ROCE | 11.91% | ||
| ROIC | 5.23% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 8.22% | ||
| OM | 2.96% | ||
| PM (TTM) | 0.99% | ||
| GM | 85.3% | ||
| FCFM | 2.22% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score7
Asset Turnover2.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.6 | ||
| Debt/FCF | 7.88 | ||
| Debt/EBITDA | 2.26 | ||
| Cap/Depr | 42.37% | ||
| Cap/Sales | 1.47% | ||
| Interest Coverage | 5.03 | ||
| Cash Conversion | 57.42% | ||
| Profit Quality | 224.33% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 3.43 |
F-Score7
WACC5.07%
ROIC/WACC1.03
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)200.98%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%9.8%
EPS Next Y79.75%
EPS Next 2Y72.14%
EPS Next 3Y59.17%
EPS Next 5Y40.9%
Revenue 1Y (TTM)12.6%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%13.44%
Revenue Next Year11.29%
Revenue Next 2Y11.26%
Revenue Next 3Y11.01%
Revenue Next 5Y10.64%
EBIT growth 1Y38.36%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year308.27%
EBIT Next 3Y79.27%
EBIT Next 5Y45.14%
FCF growth 1Y300.77%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y1010.67%
OCF growth 3Y32.14%
OCF growth 5Y37.69%
ADESSO SE / ADN1.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.
Can you provide the valuation status for ADESSO SE?
ChartMill assigns a valuation rating of 6 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.
How profitable is ADESSO SE (ADN1.DE) stock?
ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.
What is the financial health of ADESSO SE (ADN1.DE) stock?
The financial health rating of ADESSO SE (ADN1.DE) is 4 / 10.
Can you provide the dividend sustainability for ADN1 stock?
The dividend rating of ADESSO SE (ADN1.DE) is 5 / 10 and the dividend payout ratio is 31.75%.